IL97775A - T-CELL LYMPHOMA cDNA CLONES - Google Patents

T-CELL LYMPHOMA cDNA CLONES

Info

Publication number
IL97775A
IL97775A IL97775A IL9777591A IL97775A IL 97775 A IL97775 A IL 97775A IL 97775 A IL97775 A IL 97775A IL 9777591 A IL9777591 A IL 9777591A IL 97775 A IL97775 A IL 97775A
Authority
IL
Israel
Prior art keywords
cells
cell
cdna
dna
gene
Prior art date
Application number
IL97775A
Other languages
English (en)
Other versions
IL97775A0 (en
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL97775A0 publication Critical patent/IL97775A0/xx
Priority to IL11158294A priority Critical patent/IL111582A0/xx
Publication of IL97775A publication Critical patent/IL97775A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
IL97775A 1990-04-13 1991-04-04 T-CELL LYMPHOMA cDNA CLONES IL97775A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11158294A IL111582A0 (en) 1991-04-04 1994-11-10 Gene encoding cationic amino acid transporter protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50968490A 1990-04-13 1990-04-13

Publications (2)

Publication Number Publication Date
IL97775A0 IL97775A0 (en) 1992-06-21
IL97775A true IL97775A (en) 1998-04-05

Family

ID=24027673

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97775A IL97775A (en) 1990-04-13 1991-04-04 T-CELL LYMPHOMA cDNA CLONES

Country Status (21)

Country Link
US (2) US5312733A (pt)
EP (1) EP0527813B1 (pt)
JP (1) JPH05506989A (pt)
KR (1) KR100212371B1 (pt)
AT (1) ATE141105T1 (pt)
AU (1) AU664535B2 (pt)
CA (1) CA2080018C (pt)
DE (1) DE69121240T2 (pt)
DK (1) DK0527813T3 (pt)
ES (1) ES2093100T3 (pt)
FI (1) FI108037B (pt)
GR (1) GR3021478T3 (pt)
IE (1) IE75903B1 (pt)
IL (1) IL97775A (pt)
NO (1) NO307341B1 (pt)
NZ (1) NZ237669A (pt)
PT (1) PT97355B (pt)
RU (1) RU2116346C1 (pt)
SA (1) SA92120348B1 (pt)
WO (1) WO1991016430A1 (pt)
ZA (1) ZA912489B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6784163B1 (en) * 1990-04-13 2004-08-31 Macleod Carol L. Inhibition of cationic amino acid transporter protein and uses thereof
WO1994004567A1 (en) * 1992-08-21 1994-03-03 La Jolla Cancer Research Foundation A matrix-associating dna-protein, nucleic acids encoding the same and methods for detecting the nucleic acids
US7211259B1 (en) 1993-05-07 2007-05-01 Immunex Corporation 4-1BB polypeptides and DNA encoding 4-1BB polypeptides
US7138500B1 (en) 1993-05-07 2006-11-21 Immunex Corporation Antibodies to human 4-1BB
US5674704A (en) * 1993-05-07 1997-10-07 Immunex Corporation Cytokine designated 4-IBB ligand
US5866329A (en) * 1995-09-27 1999-02-02 Demetriou; Achilles A. Method and probe for detection of gene associated with liver neoplastic disease
US5861248A (en) * 1996-03-29 1999-01-19 Urocor, Inc. Biomarkers for detection of prostate cancer
US6627199B1 (en) * 1999-07-09 2003-09-30 Amgen Inc Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
US20030096355A1 (en) * 1999-07-09 2003-05-22 Ke Zhang Isolation, identification and characterization of ymkz5, a novel member of the TNF-receptor supergene family
AU783682B2 (en) * 1999-08-04 2005-11-24 Amgen, Inc. Fhm, a novel member of the TNF ligand supergene family
WO2001010908A1 (en) * 1999-08-04 2001-02-15 Amgen Inc. Ntr3, a member of the tnf-receptor supergene family
AU2002330713A1 (en) * 2001-09-24 2003-04-07 University Of Aarhus Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
DE10208175A1 (de) * 2002-02-20 2003-09-04 Medinnova Ges Med Innovationen Nukleotidsequenz codierend für ein TolC sowie eine definierte Aminosäurensequenz
US20100021953A1 (en) * 2005-08-03 2010-01-28 Astrazeneca Ab Method for Identifying an Agent that Modulates Arginine Transport in a Chondrocyte
CN101313061B (zh) * 2005-11-18 2013-05-15 大学健康网络 扩增双阴性t细胞的方法
RU2536941C2 (ru) * 2009-06-10 2014-12-27 Стефен Саниг Ресерч Инститьют Лтд. Способы получения клеток, проявляющих фенотипическую пластичность

Also Published As

Publication number Publication date
AU7745791A (en) 1991-11-11
ATE141105T1 (de) 1996-08-15
EP0527813A4 (en) 1993-05-05
ZA912489B (en) 1992-01-29
GR3021478T3 (en) 1997-01-31
NO307341B1 (no) 2000-03-20
CA2080018C (en) 2003-10-14
KR100212371B1 (ko) 1999-08-02
US5312733A (en) 1994-05-17
NZ237669A (en) 1992-08-26
DE69121240D1 (de) 1996-09-12
JPH05506989A (ja) 1993-10-14
RU2116346C1 (ru) 1998-07-27
CA2080018A1 (en) 1991-10-14
FI924575A7 (fi) 1992-10-09
EP0527813B1 (en) 1996-08-07
SA92120348B1 (ar) 2004-01-24
EP0527813A1 (en) 1993-02-24
IE75903B1 (en) 1997-10-08
PT97355A (pt) 1991-12-31
US5440017A (en) 1995-08-08
IL97775A0 (en) 1992-06-21
FI108037B (fi) 2001-11-15
IE911250A1 (en) 1991-10-23
NO923918L (no) 1992-12-01
DE69121240T2 (de) 1997-01-09
PT97355B (pt) 1998-08-31
HK1006726A1 (en) 1999-03-12
KR930700657A (ko) 1993-03-15
DK0527813T3 (da) 1996-12-30
ES2093100T3 (es) 1996-12-16
FI924575A0 (fi) 1992-10-09
WO1991016430A1 (en) 1991-10-31
NO923918D0 (no) 1992-10-08
AU664535B2 (en) 1995-11-23

Similar Documents

Publication Publication Date Title
US5440017A (en) T-cell lymphoma cDNA clones
Yamamura et al. Functional expression of a microinjected E d α gene in C57BL/6 transgenic mice
Goyert et al. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors
USRE35585E (en) DNA vector with isolated cDNA gene encoding metallopanstimulin
Macleod et al. Activated T cells express a novel gene on chromosome 8 that is closely related to the murine ecotropic retroviral receptor
NZ239828A (en) Cdna clone obtained from a t-lymphoma library (pem), the protein coded for and their uses
JPH11505125A (ja) 血管拡張性運動失調症遺伝子及びそのゲノム構成
Reuss et al. cDNA sequence and genomic characterization of intracisternal A-particle-related retroviral elements containing an envelope gene
Jiang et al. Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma
JP3779989B2 (ja) リンパ抗原ｃｄ３０
JP3445586B2 (ja) Ｄｎａプローブの開発およびヒト腫瘍関連抗原の免疫学的試薬
US5866123A (en) Gene encoding cationic amino acid transporter protein
HK1006726B (en) T-CELL LYMPHOMA cDNA CLONES
WO1999003883A1 (en) Compositions and methods based upon the tuberous sclerosis-1 (tsc1) gene and gene product
US7108994B2 (en) Receptor-type phosphotyrosine phosphatase-alpha
KR20010102996A (ko) 메그-4 단백질
EP0435877A1 (en) Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response
JP2000512133A (ja) 多発性骨髄腫で変化した遺伝子の同定
JPH06503476A (ja) ヒトレトロウイルスレセプター及びそれをコードするｄｎａ
Kurtz Identification and characterization of the murine Cr2 gene, the evolutionary homologue to the human CR2 gene
Lai et al. Human Retinoblastoma Susceptibility Gene
JPWO2000044783A1 (ja) メグ−４タンパク質

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees